MS Stock Analysis: Morgan Stanley | NYSE
Capital Markets | NYSE, USA | Market Cap: 286.000m USD | 12M Return: 16.4% | US6174464486 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.11B
EPS Trend: 99.2%
Qual. Beats: 5
Rev. Trend: 99.5%
Qual. Beats: 6
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Morgan Stanley (NYSE: MS) is a global financial holding company headquartered in New York, founded in 1924 and listed since 1993. It operates through three core segments: Institutional Securities, Wealth Management, and Investment Management, serving corporations, governments, financial institutions, and individuals across the Americas, Asia, Europe, the Middle East, and Africa. Within the Financials sector, the firm is classified under the Investment Banking & Brokerage sub-industry, reflecting its roots and continued emphasis on capital markets activity alongside its growing asset and wealth management franchises.
The Institutional Securities segment encompasses the firms investment banking and capital markets businesses, including equity and fixed income underwriting, mergers and acquisitions advisory, restructurings, and project finance. It also covers sales, financing, prime brokerage, and market-making activities, as well as corporate and commercial real estate lending, securities-based financing, and research. This segment reflects the traditional investment banking model, in which advisory fees, underwriting spreads, and trading revenues are the primary drivers of earnings.
The Wealth Management segment serves individual investors and intermediaries through financial advisor-led brokerage, self-directed brokerage, investment advisory, custody, cash management, banking, retirement plan services, and lending products such as residential real estate and securities-based loans. The Investment Management segment provides equity, fixed income, alternatives, solutions, and liquidity and overlay services to institutional and individual clients, including pension plans, foundations, endowments, sovereign wealth funds, and insurance companies. Together, these two segments anchor the firms recurring fee-based revenue model, complementing the more cyclical performance of its institutional securities business.
- Wealth Management fee revenues grow on expanding advisor-led AUM
- Investment banking advisory revenue rises on M&A recovery
- Net interest income moves with Fed rate cuts
| Net Income: 20.5b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 0.61 > 1.0 |
| NWC/Revenue: -338.7% < 20% (prev -556.6%; Δ 217.9% < -1%) |
| CFO/TA -0.01 > 3% & CFO -15.6b > Net Income 20.5b |
| Net Debt (355b) to EBITDA (31.3b): 11.35 < 3 |
| Current Ratio: 0.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.57b) vs 12m ago -1.41% < -2% |
| Gross Margin: 60.63% > 18% (prev 56.91%; Δ 3.71% > 0.5%) |
| Asset Turnover: 8.49% > 50% (prev 8.21%; Δ 0.28% > 0%) |
| Interest Coverage Ratio: 0.53 > 6 (EBIT TTM 26.6b / Interest Expense TTM 50.7b) |
| A: -0.26 (Total Current Assets 120b - Total Current Liabilities 560b) / Total Assets 1692b |
| B: 0.07 (Retained Earnings 115b / Total Assets 1692b) |
| C: 0.02 (EBIT TTM 26.6b / Avg Total Assets 1529b) |
| D: 0.09 (Book Value of Equity 112b / Total Liabilities 1308b) |
| Altman-Z'' = -1.28 = CCC |
As of October 18, 2026, the stock is trading at USD 180.57 with a total of 5,642,999 shares traded. Over the past week, the price has changed by -4.97%, over one month by -11.28%, over three months by -15.75% and over the past year by +16.38%.
Current recommended Stop Loss: 174.10 (which is 3.6% or 1.3 ATR below the current price).
Morgan Stanley has received a consensus analysts rating of 3.69. Therefore, it is recommended to hold MS.
- StrongBuy: 9
- Buy: 2
- Hold: 14
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 214.6 | 18.9% |
P/E Trailing = 15.1246
P/E Forward = 14.9477
P/S = 3.6748
P/B = 2.9499
P/EG = 1.7595
Revenue TTM = 130b USD
EBIT TTM = 26.6b USD
EBITDA TTM = 31.3b USD
Long Term Debt = 349b USD (from longTermDebt, last fiscal year)
Short Term Debt = 144b USD (from shortTermDebt, last fiscal year)
Debt = 476b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 355b USD (calculated: Debt 476b - CCE 120b)
Enterprise Value = 641b USD (286b + Debt 476b - CCE 120b)
Interest Coverage Ratio = 0.53 (Ebit TTM 26.6b / Interest Expense TTM 50.7b)
EV/FCF = -40.90x (Enterprise Value 641b / FCF TTM -15.7b)
FCF Yield = -2.45% (FCF TTM -15.7b / Enterprise Value 641b)
FCF Margin = -12.09% (FCF TTM -15.7b / Revenue TTM 130b)
Net Margin = 15.82% (Net Income TTM 20.5b / Revenue TTM 130b)
Gross Margin = 60.63% ((Revenue TTM 130b - Cost of Revenue TTM 51.1b) / Revenue TTM)
Gross Margin QoQ = 60.67% (prev 61.65%)
Tobins Q-Ratio = 0.38 (Enterprise Value 641b / Total Assets 1692b)
Interest Expense / Debt = 10.67% (Interest Expense 50.7b / Debt 476b)
Taxrate = 22.23% (5.91b / 26.6b)
NOPAT = 20.7b (EBIT 26.6b * (1 - 22.23%))
Current Ratio = 0.21 (Total Current Assets 120b / Total Current Liabilities 560b)
Debt / Equity = 4.26 (Debt 476b / totalStockholderEquity, last fiscal year 112b)
Debt / EBITDA = 11.35 (Net Debt 355b / EBITDA 31.3b)
Debt / FCF = -22.66 (negative FCF - burning cash) (Net Debt 355b / FCF TTM -15.7b)
Total Stockholder Equity = 112b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.34% (Net Income 20.5b / Total Assets 1692b)
RoE = 18.40% (Net Income TTM 20.5b / Total Stockholder Equity 112b)
RoCE = 5.78% (EBIT 26.6b / Capital Employed (Equity 112b + L.T.Debt 349b))
RoIC = 1.63% (NOPAT 20.7b / Invested Capital 1270b)
WACC = 9.24% (E(286b)/V(762b) * Re(10.81%) + D(476b)/V(762b) * Rd(10.67%) * (1-Tc(0.22)))
Discount Rate = 10.81% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -89.24 | Cagr: -1.12%
[DCF] Fair Price = unknown (Cash Flow -15.7b)
EPS Correlation: 99.25 | EPS CAGR: 38.59% | SUE: 1.10 | # QB: 5
Revenue Correlation: 99.52 | Revenue CAGR: 13.67% | SUE: 0.92 | # QB: 6
EPS current Quarter (2027-03-31): EPS=3.62 | Chg30d=-1.88% | Revisions=-29% | Analysts=10
EPS current Year (2026-12-31): EPS=12.81 | Chg30d=-1.35% | Revisions=-75% | GrowthEPS=+25.4% | GrowthRev=+16.2%
EPS next Year (2027-12-31): EPS=13.64 | Chg30d=-0.40% | Revisions=-45% | GrowthEPS=+6.5% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: -63% (up=6, down=32)